4
Changes in Ownership
Mineralys Therapeutics, Inc. Filed Acc 0001672659-26-000004
Chief Medical Officer sold 8,518 shares at an average $32.56 ($277,339)
- Chief Medical Officer acquired 8,518 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Rodman David Malcom Chief Medical Officer | 2026-01-09 | Option exercise 10b5-1 | +2,170 | $16.00 | $34,720 | 63,974 | D |
| Rodman David Malcom Chief Medical Officer | 2026-01-09 | Sale 10b5-1 | −2,170 | $33.27 | $72,196 | 61,804 | D |
| Rodman David Malcom Chief Medical Officer | 2026-01-12 | Option exercise 10b5-1 | +6,348 | $1.08 | $6,856 | 68,152 | D |
| Rodman David Malcom Chief Medical Officer | 2026-01-12 | Sale 10b5-1 | −6,348 | $32.32 | $205,143 | 61,804 | D |
| Derivatives | |||||||
| Rodman David Malcom Chief Medical Officer | 2026-01-09 | Option exercise · Stock Option 10b5-1 | −2,170 | 28,218 | D | ||
| Rodman David Malcom Chief Medical Officer | 2026-01-12 | Option exercise · Stock Option 10b5-1 | −6,348 | 38,092 | D | ||
| Open-market sales · 8,518 sh · avg $32.56 · $277,339 | |||||||
Loading xslF345X05/wk-form4_1768355008.xml…